Lilly’s Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays

Investing.com Gold reports: Lilly’s Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays. Full body text was unavailable at ingest time, so this brief is based on headline context.